"10.1371_journal.pone.0081950","plos one","2013-12-11T00:00:00Z","Mark-Oliver Rödel; Christian Brede; Mareike Hirschfeld; Thomas Schmitt; Philippe Favreau; Reto Stöcklin; Cora Wunder; Dietrich Mebs","Museum für Naturkunde Berlin, Leibniz Institute for Research on Evolution and Biodiversity, Berlin, Germany; Theodor-Boveri-Institute (Biocenter of the University), Department of Animal Ecology and Tropical Biology (Zoology III), Würzburg, Germany; Atheris Laboratories, Bernex, Switzerland; Institute of Legal Medicine, University of Frankfurt, Frankfurt/M., Germany; Medizinische Klinik und Poliklinik II, Zentrum für Experimentelle Molekulare Medizin, Würzburg, Germany; Ecological Networks, Biology, Technische Universität Darmstadt, Darmstadt, Germany","Conceived and designed the experiments: MOR TS DM. Performed the experiments: MOR MH CB DM TS PF RS CW. Analyzed the data: MOR DM CB TS. Contributed reagents/materials/analysis tools: DM PF RS. Wrote the paper: MOR DM. Field work: MOR MH CB.","This is to certify that Reto Stocklin is the co-founder, owner, president and CEO of Atheris Laboratories, a biotechnology company working in the field of discovery of bio-active molecules from animal venoms and other natural origins. This does not alter the authors′ adherence to all the PLOS ONE policies on sharing data and materials of the work submitted, and the authors hereby certify that there is no financial or non-financial competing of interest for this manuscript to be published, in accordance with the PLOS ONE policies.","2013","12","Mark-Oliver Rödel","MOR",8,TRUE,3,8,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
